Three-year inhibition of aldose reductase on development of symptomatic neuropathy in diabetic patients.
Baba
Masayuki
M
Kimura
Ken-ichi
K
Suda
Toshihiro
T
Yagihashi
Soroku
S
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors / Q000502:physiology*; D003920:Diabetes Mellitus / Q000188:drug therapy; D003929:Diabetic Neuropathies / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D004311:Double-Blind Method; D004558:Electric Stimulation / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009431:Neural Conduction / Q000187:drug effects / Q000502:physiology; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D012236:Rhodanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D053778:Thiazolidines
D053778:Thiazolidines; C038131:epalrestat; D012236:Rhodanine; D000449:Aldehyde Reductase